Skip to content
10-K

Annual Report

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB

0001299130-25-000061

← back to feed
Filed
Mar 17, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 28, 2025 297.85M sh
Short Term Debt FY 2024 · Dec 31, 2024 $0
Short Term Debt FY 2024 · Dec 31, 2023 $490K
Short Term Investments FY 2024 · Dec 31, 2023 $451.51M
Current Liabilities FY 2024 · Dec 31, 2023 $95.03M
Total Liabilities FY 2024 · Dec 31, 2023 $1.04B
Current Assets FY 2024 · Dec 31, 2023 $742.05M
Total Assets FY 2024 · Dec 31, 2023 $1.75B
Shares Diluted FY 2024 · Dec 31, 2022 224.55M sh
Capex FY 2024 · Dec 31, 2022 $16.75M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$263.21M
Cash And Equivalents FY 2024 · Dec 31, 2022 $325.09M
Eps Diluted FY 2024 · Dec 31, 2022 −$1.40
Eps Basic FY 2024 · Dec 31, 2022 −$1.40
Sga Expense FY 2024 · Dec 31, 2022 $160.85M
Rd Expense FY 2024 · Dec 31, 2022 $193M
Net Income FY 2024 · Dec 31, 2022 −$314.25M
Operating Income FY 2024 · Dec 31, 2022 −$307.2M
Gross Profit FY 2024 · Dec 31, 2022 $49.04M
Cost Of Revenue FY 2024 · Dec 31, 2022 $79.27M
Stockholders Equity FY 2024 · Dec 31, 2021 $790.99M